Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention.

Wimmer NJ, Yeh RW.

Trends Cardiovasc Med. 2012 Jan;22(1):23-8. doi: 10.1016/j.tcm.2012.06.006. Epub 2012 Jul 28. Review.

PMID:
22841840
[PubMed - indexed for MEDLINE]
2.

Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice.

Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand SL, Rumsfeld JS, Messenger JC, Yeh RW.

Arch Intern Med. 2012 Aug 13;172(15):1145-52. doi: 10.1001/archinternmed.2012.3093.

PMID:
22777536
[PubMed - indexed for MEDLINE]
3.

Post percutaneous coronary intervention antiplatelet therapy: current perceptions, prospects and perplexity.

Pant S, Neupane P, Ramesh KC, Barakoti M.

Cardiol J. 2011;18(6):712-7.

PMID:
22113766
[PubMed - indexed for MEDLINE]
Free Article
4.

Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials.

Tamhane U, Meier P, Chetcuti S, Chen KY, Rha SW, Grossman MP, Gurm H.

EuroIntervention. 2009 Aug;5(3):384-93. Review.

PMID:
19736165
[PubMed - indexed for MEDLINE]
5.

Duration of dual antiplatelet therapy following percutaneous coronary intervention with drug-eluting stents: a review of recent evidence.

Acharjee S, Cannon CP.

Crit Pathw Cardiol. 2010 Dec;9(4):203-6. doi: 10.1097/HPC.0b013e318200f5ea. Review.

PMID:
21119338
[PubMed - indexed for MEDLINE]
6.

Management of drug-eluting stent restenosis.

Ishikawa K, Aoyama Y, Hirayama H.

J Invasive Cardiol. 2012 Apr;24(4):178-82. Review.

PMID:
22477755
[PubMed - indexed for MEDLINE]
Free Article
7.

Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model.

Garg P, Cohen DJ, Gaziano T, Mauri L.

J Am Coll Cardiol. 2008 May 13;51(19):1844-53. doi: 10.1016/j.jacc.2008.01.042.

PMID:
18466798
[PubMed - indexed for MEDLINE]
Free Article
8.

Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment.

Byrne RA, Sarafoff N, Kastrati A, Schömig A.

Drug Saf. 2009;32(9):749-70. doi: 10.2165/11316500-000000000-00000. Review.

PMID:
19670915
[PubMed - indexed for MEDLINE]
9.

Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention.

Yeh RW, Normand SL, Wolf RE, Jones PG, Ho KK, Cohen DJ, Cutlip DE, Mauri L, Kugelmass AD, Amin AP, Spertus JA.

Circulation. 2011 Oct 4;124(14):1557-64. doi: 10.1161/CIRCULATIONAHA.111.045229. Epub 2011 Sep 6.

PMID:
21900079
[PubMed - indexed for MEDLINE]
Free Article
10.

Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.

Doostzadeh J, Clark LN, Bezenek S, Pierson W, Sood PR, Sudhir K.

Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Review.

PMID:
19952925
[PubMed - indexed for MEDLINE]
11.

Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.

Wijnbergen I, Helmes H, Tijssen J, Brueren G, Peels K, van Dantzig JM, Van' t Veer M, Koolen JJ, Pijls NH, Michels R.

JACC Cardiovasc Interv. 2012 Mar;5(3):313-22. doi: 10.1016/j.jcin.2011.11.009.

PMID:
22440498
[PubMed - indexed for MEDLINE]
Free Article
12.

First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.

Belkacemi A, Agostoni P, Nathoe HM, Voskuil M, Shao C, Van Belle E, Wildbergh T, Politi L, Doevendans PA, Sangiorgi GM, Stella PR.

J Am Coll Cardiol. 2012 Jun 19;59(25):2327-37. doi: 10.1016/j.jacc.2012.02.027. Epub 2012 Apr 11.

PMID:
22503057
[PubMed - indexed for MEDLINE]
Free Article
13.

Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J.

Circulation. 2012 Jun 12;125(23):2873-91. doi: 10.1161/CIRCULATIONAHA.112.097014. Epub 2012 May 14.

PMID:
22586281
[PubMed - indexed for MEDLINE]
Free Article
14.

Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.

Spinler SA.

Am J Manag Care. 2009 Mar;15(2 Suppl):S42-7. Review.

PMID:
19355808
[PubMed - indexed for MEDLINE]
Free Article
15.

Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?

Valgimigli M, Airoldi F, Zimarino M.

J Cardiovasc Med (Hagerstown). 2009 Oct;10 Suppl 1:S17-26. doi: 10.2459/01.JCM.0000362040.25767.f5. Review.

PMID:
19851216
[PubMed - indexed for MEDLINE]
16.

[Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].

Koziński M, Sukiennik A, Sinkiewicz W, Kochman W, Kubica J.

Postepy Hig Med Dosw (Online). 2008 May 8;62:185-205. Review. Polish.

PMID:
18464681
[PubMed - indexed for MEDLINE]
Free Article
17.

The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.

Simsek C, Magro M, Boersma E, Onuma Y, Nauta ST, Gaspersz MP, van der Giessen WJ, van Domburg RT, Serruys PW; Interventional Cardiologists of the Thoraxcenter.

JACC Cardiovasc Interv. 2010 Oct;3(10):1051-8. doi: 10.1016/j.jcin.2010.08.003.

PMID:
20965464
[PubMed - indexed for MEDLINE]
Free Article
18.

Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.

Mirabella F, Francaviglia B, Capodanno D, Di Salvo ME, Galassi AR, Ussia GP, Capranzano P, Tamburino C.

J Invasive Cardiol. 2009 Apr;21(4):145-50.

PMID:
19342750
[PubMed - indexed for MEDLINE]
Free Article
19.

Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease.

Bonaventura K, Leber AW, Sohns C, Roser M, Boldt LH, Kleber FX, Haverkamp W, Dorenkamp M.

Clin Res Cardiol. 2012 Jul;101(7):573-84. doi: 10.1007/s00392-012-0428-2. Epub 2012 Feb 21.

PMID:
22350752
[PubMed - indexed for MEDLINE]
20.

Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.

Onuma Y, Kukreja N, Daemen J, Garcia-Garcia HM, Gonzalo N, Cheng JM, van Twisk PH, van Domburg R, Serruys PW; Interventional Cardiologists of Thoraxcenter.

JACC Cardiovasc Interv. 2009 Jul;2(7):603-10. doi: 10.1016/j.jcin.2009.03.016.

PMID:
19628181
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk